A randomized, open-label study of 2 different treatment durations of PEGASYS [peginterferon alfa-2a] on ALT [alaniine aminotransferase] normalization in treatment-naive patients with chronic hepatitis B infection
Phase of Trial: Phase III
Latest Information Update: 02 Jun 2010
At a glance
- Drugs Peginterferon alfa-2a (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Roche
- 18 Apr 2009 Status changed from active, no longer recruiting to completed as reported by Roche record.
- 26 Jun 2006 New trial record.